What Richmond Behavioral Associates does

Richmond Behavioral Associates (RBA) is a clinical research site founded in 2016 by Dr. Adam Smith in Staten Island, New York, operating as a portfolio company within the Evolution Research Group (ERG) Network of research sites. The company conducts Phase I-IV clinical trials across central nervous system (CNS) indications including depression, anxiety, bipolar disorder, schizophrenia, addiction, Alzheimer's disease, insomnia, and autism spectrum disorder, and has launched the Advanced Memory Institute as a dedicated sub-brand for memory disorder trials. RBA serves pharmaceutical sponsors and Contract Research Organizations (CROs) requiring investigator site services, and serves patient-volunteers seeking access to investigational treatments for psychiatric and memory conditions.

RBA operates from a custom-designed 5,000 square foot facility at 260 Christopher Lane, Staten Island, equipped with two dedicated monitoring offices, two examination/testing rooms, a dedicated drug room, -70°C and -20°C freezers, refrigerated centrifuge, and lab hood for vaccine preparation. The investigator team includes Dr. Peter Weiden (a recognized key opinion leader in schizophrenia research with 100+ publications and PI/co-PI experience on 80+ trials), Dr. Adam Smith (founder, clinical psychology doctorate from Nova Southeastern University), and Dr. Romana Kulikova (pediatric neurologist, joined July 2024). RBA's proprietary technology asset is the MyTrial App (Version 2 launched January 2026), a patient-facing mobile application offering appointment scheduling, Uber ride integration, refer-a-friend functionality, patient notifications, and bilingual English/Spanish support.

RBA's revenue model is professional services-based, generating fees from pharmaceutical sponsors and CROs for clinical trial conduct, facility access, investigator time, and patient recruitment. Marketing to sponsors is conducted through the ERG Network's centralized ERGClinical.com platform and direct sponsor relationships. Patient recruitment leverages community partnerships (NAMI Staten Island, STARR Coalition, Global Alzheimer's Platform, SCRS, CNS Summit), physician referrals, the MyTrial App refer-a-friend feature, and a statewide free memory screening initiative launched in 2025. In 2024, RBA expanded into Medicare-funded care coordination through the GUIDE dementia pilot with Advanced Memory Group, introducing a payer-funded revenue stream beyond traditional sponsor fees.

Name

Richmond Behavioral Associates

Legal name

Richmond Behavioral Associates

Website

https://rbany.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

1–10 employees

Short description

Richmond Behavioral Associates is a Staten Island-based clinical research site within the ERG Network, conducting Phase I-IV trials for CNS disorders including schizophrenia, Alzheimer's, and autism for pharmaceutical sponsors, CROs, and patient volunteers.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Offices of Physicians, Mental Health Specialists (621112)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industry

Outpatient Mental Health Clinics & Counseling Centers (HLAFACAA)

Keywords

• Clinical trial services
• CNS clinical research
• Psychiatric clinical trials
• Clinical research site
• Phase I-IV trials

Headquarters

HQ city

Staten Island

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Clinical Trial Services: Revenue is generated by conducting clinical trials for pharmaceutical companies and CROs across Phase I-IV studies. The company provides research facility, staff, patient recruitment, and regulatory compliance services in exchange for contract fees.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Richmond Behavioral Associates operates as a clinical research site conducting Phase I-IV clinical trials for central nervous system (CNS) disorders including depression, anxiety, bipolar disorder, schizophrenia, addiction, Alzheimer's disease, and insomnia. The company delivers full-service trial execution for pharmaceutical sponsors and CROs, providing experienced investigators, qualified staff, patient recruitment, regulatory compliance, and a custom-designed 5,000 sq ft research facility. Patient recruitment and engagement are supported through community partnerships, physician referrals, and the proprietary MyTrial App.

Product overview

Richmond Behavioral Associates is a clinical research site company offering a portfolio of clinical trial services and digital tools. The core offering is clinical research services conducting Phase I-IV trials for CNS disorders. The MyTrial App serves as a patient-facing digital companion for managing study participation. Specialized units include the Advanced Memory Institute (focused on dementia and Alzheimer's) and Autism clinical trial programs. The company also offers free memory screening initiatives as a gateway to clinical trial enrollment. All services are integrated within the ERG (Evolution Research Group) Network of research sites.

Differentiator

Problem solved

Functional benefit

Brands

• Advanced Memory Institute: A specialized division focusing on memory disorders, dementia, and Alzheimer's disease research and treatment services.

Products and services

• Clinical Research Services Full-service Phase I-IV clinical trial execution for pharmaceutical sponsors and CROs across CNS indications including depression, anxiety, bipolar disorder, schizophrenia, addiction, Alzheimer's disease, and insomnia. Includes experienced principal investigators, qualified study coordinators, regulatory submission, patient recruitment, ECRF/data management, and dedicated monitoring offices.
• MyTrial App (Version 2) Patient-facing mobile application for managing clinical trial participation, including appointment scheduling, patient notifications, Uber ride requests to/from study visits, refer-a-friend functionality, secure communication with study coordinators, wallet access, and educational resources. Available in English and Spanish.
• Advanced Memory Institute Specialized clinical research unit focused on Alzheimer's Disease, Vascular Dementia, and Lewy Body Disease, offering clinical trials for investigational treatments, comprehensive evaluation services, and patient navigation through the Medicare GUIDE dementia pilot program.
• Autism Clinical Trials Program Clinical research program offering investigational treatment studies for Autism Spectrum Disorder (ASD), recruiting patients across the New York and New Jersey region for studies of new therapies.
• Free Memory Screening Initiative Free, confidential in-person memory screenings for adults aged 50 and older, conducted in partnership with leading New York memory specialists and Alzheimer's research centers as a gateway to clinical trial enrollment.

Quantifiable outcome

• Regulatory ready within one week, one day contract turnaround
• +2 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability4 records

Feature1 record

Partnerships

Eight partnerships are on record, tiered core and minor.

• Advanced Memory GroupcoreStrategic or Co-development Partner · 1 January 2024Richmond Behavioral Associates collaborates with Advanced Memory Group in Staten Island for the Medicare GUIDE (Guiding an Improved Dementia Experience) pilot program. RBA assigns patient navigators and coordinates medical, social, and community-based services for enrolled families receiving the $2,563 annual Medicare-funded respite benefit.
• Evolution Research Group (ERG) NetworkcoreStrategic or Co-development PartnerRichmond Behavioral Associates is an ERG portfolio company and part of the ERG Network of Research Sites. Together they form one of the largest research organizations in the nation focusing on clinical trials for psychiatric disorders, pain, Alzheimer's, hepatic, renal and other debilitating diseases.
• STARR CoalitionminorStrategic or Co-development PartnerNonprofit organization developing collaborative initiatives to reduce stigma associated with mental health disorders and promote clinical research as an option for those seeking help. Partners include pharmaceutical industry, CROs, clinical research sites, and patient advocacy groups.
• STARR 911minorStrategic or Co-development PartnerProgram bridging the gap between clinical research and suicide prevention. STARR Coalition partnered with ERG to sponsor onsite training video for research staff as first step in comprehensive training program for psychiatric clinical research participants screened for suicidal thoughts.
• Society for Clinical Research Sites (SCRS)minorStrategic or Co-development PartnerGlobal organization representing clinical research sites, providing unified voice and community dedicated to greater site sustainability. SCRS represents over 9,500 research sites in 47 countries.
• Global Alzheimer's Platform Association (GAP)minorStrategic or Co-development PartnerFoundation focused on reducing time and cost of Alzheimer's clinical research trials. GAP-Net network of 60+ leading academic and private clinical research sites across US and Canada fast-tracks patient recruitment. ERG is part of this network.
• CNS SummitminorStrategic or Co-development PartnerCommunity of leaders from pharmaceutical/biotech companies, technology companies, startups, patient advocates, investigator sites, service companies, regulators and investors. ERG is a founding patron of CNS Summit.
• NAMI: Staten IslandminorStrategic or Co-development PartnerOrganization of families, friends and individuals whose lives have been affected by mental illness, advocating for better lives for those with mental illness.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• CenExel: Large multi-site clinical research site network with therapeutic-area sites including CNS and infectious disease. Competes for sponsor protocol allocation in the same therapeutic categories as RBA, scaled across multiple US geographies.
• IQVIA: World's largest CRO and clinical research services firm with deep CNS site relationships, decentralized trial capabilities, and sponsor-driven protocol allocation. Represents both the dominant enterprise customer channel and a competitive alternative for end-to-end trial delivery.
• Medpace: Large full-service CRO with notable CNS and metabolic therapeutic area strength. As a frequent sponsor/CRO counterparty to RBA-style sites, Medpace represents both a major customer pipeline and a competitive alternative for outsourced trial execution.
• Worldwide Clinical Trials: Mid-sized global CRO with significant CNS and neuroscience franchise, frequently sponsoring Phase II-IV trials through US site networks including independent sites. Represents the typical sponsor customer of RBA and also competes for fully outsourced trial delivery.

Direct peers

• Evolution Research Group: Parent company and operator of the network of which Richmond Behavioral Associates is a portfolio site. Operates one of the largest US networks of clinical research sites focused on psychiatric, neurological, and pain trials; directly comparable service lines and shared back-office functions.
• Clinilabs: NYC-based clinical research organization specializing in CNS, sleep, and early-phase trials including healthy volunteer studies. Operates in adjacent geography and runs Phase I-IV psychiatry studies, overlapping directly with RBA's CNS site services.

Emerging players

• Flourish Research: Formed through roll-ups of independent research sites (formerly including Hassman Research Institute), Flourish operates a growing network across the US with overlap in psychiatry, neurology, and Alzheimer's trials. Competes head-to-head for Phase II-IV CNS protocols.

Regional players

• Hassman Research Institute: New Jersey-based clinical research site with longstanding CNS, psychiatry, and Alzheimer's focus. Now part of Flourish Research, it historically competed with RBA for the same regional patient populations and sponsor relationships in the NY/NJ metro.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/rbanyc
• Facebookfacebook.com/RichmondBehavioralAssociates
• Instagraminstagram.com/rba.nyc

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Richmond Behavioral Associates